John Munkhaugen Prof (J Munkhaugen, John Munkhaugen)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 8

Top Topics

Smoking Cessation

Glycemic Control

Transcatheter Aortic Valve Replacement

Top Venues

European heart journal open

European heart journal. Cardiovascular pharmacotherapy

European journal of preventive cardiology

BMC cardiovascular disorders

This page only lists publications with an associated author ORCID identifier.

Publications

Karin Pleym, Toril Dammen, Harald Wedon-Fekjaer, Einar Husebye, Elise Sverre, Serena Tonstad, John Munkhaugen Prof
A multi-component intervention increased access to smoking cessation treatment after hospitalization for atherosclerotic cardiovascular disease: a randomized trial. European heart journal open 4 (2) (2024)
Jonas Pivoriunas, Nils Tore Vethe, Einar Husebye, Morten Wang Fagerland, Stein Bergan, Oscar Kristiansen, John Munkhaugen Prof, Elise Sverre
Validation of a novel direct method to determine reduced adherence to atorvastatin therapy. European heart journal. Cardiovascular pharmacotherapy 10 (4) (2024)
Karin Pleym, Toril Dammen, Harald Wedon-Fekjaer, Einar Husebye, Elise Sverre, Serena Tonstad, John Munkhaugen Prof
A multi-component intervention increased access to smoking cessation treatment after hospitalization for atherosclerotic cardiovascular disease: a randomized trial. European heart journal open 4 (2) (2024)
Jonas Pivoriunas, Nils Tore Vethe, Einar Husebye, Morten Wang Fagerland, Stein Bergan, Oscar Kristiansen, John Munkhaugen Prof, Elise Sverre
Validation of a novel direct method to determine reduced adherence to atorvastatin therapy. European heart journal. Cardiovascular pharmacotherapy (2024)
Tone Merete Norekvål, M Bale, H K Bedane, T Hole, C B Ingul, John Munkhaugen Prof
Cardiac rehabilitation participation within 6 months of discharge in 37 136 myocardial infarction survivors: a nationwide registry study. European journal of preventive cardiology (2023)
Elise Sverre, Kari Peersen, Oscar Kristiansen, Morten W Fagerland, Joep Perk, Einar Husebye, Nils Tore Vethe, Toril Dammen, John Munkhaugen Prof
Tailored clinical management after blinded statin challenge improved the lipid control in coronary patients with self-perceived muscle side effects. Journal of internal medicine 291 (6) (2022)
Ingrid Engebretsen, John Munkhaugen Prof, Christoffer Bugge, Sigrun Halvorsen, Kristina Malene Ødegaard, Eeva-Liisa Røssell Johansen, Ivar Sønbø Kristiansen
Gaps and discontinuation of statin treatment in Norway: potential for optimizing management of lipid lowering drugs. European heart journal open 2 (6) (2022)
John Munkhaugen Prof, Jøran Hjelmesæth, Jan Erik Otterstad, Ragnhild Helseth, Stina Therese Sollid, Erik Gjertsen, Lars Gullestad, Joep Perk, Torbjørn Moum, Einar Husebye, Toril Dammen
Managing patients with prediabetes and type 2 diabetes after coronary events: individual tailoring needed - a cross-sectional study. BMC cardiovascular disorders 18 (1) (2018)